查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1692183

心肺压力测试系统市场 - 全球产业规模、份额、趋势、机会和预测，按产品、应用、最终用户、地区和竞争细分，2020-2030F

Cardiopulmonary Stress Testing System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End user, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 187 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球心肺压力测试系统市场价值为 51.2 亿美元，预计在预测期内将实现令人瞩目的成长，到 2030 年的复合年增长率为 6.11%。近年来，全球心肺压力测试系统市场经历了显着增长，推动因素包括心血管和呼吸系统疾病发病率不断上升、对早期诊断重要性的认识不断提高、技术进步以及人口老化日益加剧。心肺压力测试系统在评估心臟和肺部的功能能力方面发挥着至关重要的作用，使其成为医疗保健提供者诊断和管理心臟和肺部疾病的重要工具。

市场概况
预测期 2026-2030
2024 年市场规模 51.2 亿美元
2030 年市场规模 72.5 亿美元
2025-2030 年复合年增长率 6.11％
成长最快的领域 脉搏血氧仪
最大的市场 北美洲

主要市场驱动因素

心血管和呼吸系统疾病的增加正在推动全球心肺压力测试系统市场的发展

主要市场挑战

设备和维护成本高

主要市场趋势

技术进步

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第五章：全球心肺压力测试系统市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依产品（脉搏血氧仪、压力血压监测仪、压力心电图）
    • 按应用（术前评估、运动压力测试）
    • 按最终使用者（医院和诊所、门诊护理中心、其他）
    • 按地区
    • 按公司划分（前五大市场参与者的份额，2024 年）
  • 市场地图
    • 按产品
    • 按应用
    • 按最终用户
    • 按地区

第六章：北美心肺压力测试系统市场展望

  • 市场规模和预测
  • 市场占有率和预测

第七章：欧洲心肺压力测试系统市场展望

  • 市场规模和预测
  • 市场占有率和预测

第 8 章：亚太地区心肺压力测试系统市场展望

  • 市场规模和预测
  • 市场占有率和预测

第九章：南美洲心肺压力测试系统市场展望

  • 市场规模和预测
  • 市场占有率和预测

第 10 章：中东和非洲心肺压力测试系统市场展望

  • 市场规模和预测
  • 市场占有率和预测

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 合併与收购
  • 技术发布

第 13 章：竞争格局

  • Koninklijke Philips NV.
  • Hillrom Services Inc.
  • General Electric Company
  • MGC Diagnostics Corporation.
  • OSI Systems Inc.
  • Schiller AG
  • NIHON KOHDEN CORPORATION
  • Vyaire Medical, Inc.
  • Halma plc (SunTech Medical, Inc.)
  • Cosmed srl

第 14 章：策略建议

第15章调查会社について・免责事项

简介目录
Product Code: 17388

Global Cardiopulmonary Stress Testing System Market was valued at USD 5.12 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.11% through 2030. The global Cardiopulmonary Stress Testing System market has witnessed significant growth in recent years, driven by various factors such as the increasing prevalence of cardiovascular and respiratory diseases, rising awareness about the importance of early diagnosis, advancements in technology, and a growing aging population. Cardiopulmonary stress testing systems play a crucial role in assessing the functional capacity of the heart and lungs, making them vital tools for healthcare providers in diagnosing and managing cardiac and pulmonary conditions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.12 Billion
Market Size 2030USD 7.25 Billion
CAGR 2025-20306.11%
Fastest Growing SegmentPulse Oximeter
Largest MarketNorth America

Key Market Drivers

Increasing cardiovascular and respiratory disorders is driving the Global Cardiopulmonary Stress Testing System Market

Cardiovascular and respiratory disorders pose a significant global health challenge, affecting millions of individuals and straining healthcare systems worldwide. These disorders, which include conditions such as heart disease, hypertension, asthma, and chronic obstructive pulmonary disease (COPD), can have severe consequences on an individual's health and quality of life. In response to this growing health concern, the global cardiopulmonary stress testing system market is experiencing rapid growth as healthcare providers seek innovative solutions for early diagnosis, monitoring, and management of these conditions. For instance, in 2025, Respiratory Pathology and Cardiovascular Diseases: A Scoping Review explores the connection between respiratory conditions and cardiovascular diseases, providing insights into their interplay and potential diagnostic or treatment advancements.

Key Market Challenges

High Cost of Equipment and Maintenance

One of the primary challenges in the cardiopulmonary stress testing system market is the high cost associated with both purchasing and maintaining the equipment. These systems are complex, incorporating advanced technologies like gas analyzers, electrocardiogram machines, and specialized software. Healthcare providers, particularly in low-resource settings, may find it financially burdensome to invest in these expensive systems. The ongoing maintenance and calibration requirements add to the overall cost of ownership, making it difficult for some facilities to sustain these technologies.

Key Market Trends

Technological Advancements

The Advancements in technology have permeated every aspect of our lives, including healthcare. In the realm of medical diagnostics, cardiopulmonary stress testing systems have witnessed a significant surge in demand and sophistication. These systems play a pivotal role in assessing a patient's cardiovascular and pulmonary health under stress conditions, helping healthcare professionals make more accurate diagnoses and treatment decisions. The global cardiopulmonary stress testing system market is experiencing robust growth, primarily fueled by innovations in technology and the growing prevalence of cardiovascular and pulmonary diseases.

One of the most notable technological advancements in this field is the integration of advanced sensors and wearables. These devices can continuously monitor a patient's heart rate, blood pressure, oxygen saturation, and respiratory parameters during exercise, providing real-time data for more precise assessments. This data can be analyzed instantly or remotely, enabling physicians to make timely decisions. AI and machine learning algorithms have made it possible to process and interpret the vast amount of data generated during cardiopulmonary stress tests more efficiently and accurately. AI-driven systems can detect subtle abnormalities in the data, allowing for early detection of cardiovascular and pulmonary disorders. The COVID-19 pandemic accelerated the adoption of telemedicine and remote monitoring solutions. Cardiopulmonary stress testing systems are no exception. Patients can now perform stress tests at home or in remote locations while healthcare providers monitor their progress in real-time. This not only increases accessibility but also reduces the burden on healthcare facilities.

Key Market Players

  • Koninklijke Philips NV
  • Hillrom Services Inc.
  • General Electric Company
  • MGC Diagnostics Corporation.
  • OSI Systems Inc.
  • Schiller AG
  • NIHON KOHDEN CORPORATION
  • Vyaire Medical, Inc.
  • Halma plc (SunTech Medical, Inc.)
  • Cosmed srl

Report Scope:

In this report, the Global Cardiopulmonary Stress Testing System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiopulmonary Stress Testing System Market, By Product:

  • Pulse Oximeter
  • Stress Blood Pressure Monitor
  • Stress ECG

Cardiopulmonary Stress Testing System Market, By Application:

  • Preoperative Evaluation
  • Stress Testing In Sport

Cardiopulmonary Stress Testing System Market, By End user:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Cardiopulmonary Stress Testing System Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Cardiopulmonary Stress Testing System Market.

Available Customizations:

Global Cardiopulmonary Stress Testing System market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cardiopulmonary Stress Testing System Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Pulse Oximeter, Stress Blood Pressure Monitor, Stress ECG)
    • 5.2.2. By Application (Preoperative Evaluation, Stress Testing In Sport)
    • 5.2.3. By End user (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (Shares of Top 5 Market Players, 2024)
  • 5.3. Market Map
    • 5.3.1. By Product
    • 5.3.2. By Application
    • 5.3.3. By End user
    • 5.3.4. By Region

6. North America Cardiopulmonary Stress Testing System Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End user
    • 6.2.4. By Country
      • 6.2.4.1. United States Cardiopulmonary Stress Testing System Market Outlook
        • 6.2.4.1.1. Market Size & Forecast
        • 6.2.4.1.1.1. By Value
        • 6.2.4.1.2. Market Share & Forecast
        • 6.2.4.1.2.1. By Product
        • 6.2.4.1.2.2. By Application
        • 6.2.4.1.2.3. By End User
      • 6.2.4.2. Canada Cardiopulmonary Stress Testing System Market Outlook
        • 6.2.4.2.1. Market Size & Forecast
        • 6.2.4.2.1.1. By Value
        • 6.2.4.2.2. Market Share & Forecast
        • 6.2.4.2.2.1. By Product
        • 6.2.4.2.2.2. By Application
        • 6.2.4.2.2.3. By End User
      • 6.2.4.3. Mexico Cardiopulmonary Stress Testing System Market Outlook
        • 6.2.4.3.1. Market Size & Forecast
        • 6.2.4.3.1.1. By Value
        • 6.2.4.3.2. Market Share & Forecast
        • 6.2.4.3.2.1. By Product
        • 6.2.4.3.2.2. By Application
        • 6.2.4.3.2.3. By End User

7. Europe Cardiopulmonary Stress Testing System Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
      • 7.2.4.1. France Cardiopulmonary Stress Testing System Market Outlook
        • 7.2.4.1.1. Market Size & Forecast
        • 7.2.4.1.1.1. By Value
        • 7.2.4.1.2. Market Share & Forecast
        • 7.2.4.1.2.1. By Product
        • 7.2.4.1.2.2. By Application
        • 7.2.4.1.2.3. By End User
      • 7.2.4.2. Germany Cardiopulmonary Stress Testing System Market Outlook
        • 7.2.4.2.1. Market Size & Forecast
        • 7.2.4.2.1.1. By Value
        • 7.2.4.2.2. Market Share & Forecast
        • 7.2.4.2.2.1. By Product
        • 7.2.4.2.2.2. By Application
        • 7.2.4.2.2.3. By End User
      • 7.2.4.3. United Kingdom Cardiopulmonary Stress Testing System Market Outlook
        • 7.2.4.3.1. Market Size & Forecast
        • 7.2.4.3.1.1. By Value
        • 7.2.4.3.2. Market Share & Forecast
        • 7.2.4.3.2.1. By Product
        • 7.2.4.3.2.2. By Application
        • 7.2.4.3.2.3. By End User
      • 7.2.4.4. Italy Cardiopulmonary Stress Testing System Market Outlook
        • 7.2.4.4.1. Market Size & Forecast
        • 7.2.4.4.1.1. By Value
        • 7.2.4.4.2. Market Share & Forecast
        • 7.2.4.4.2.1. By Product
        • 7.2.4.4.2.2. By Application
        • 7.2.4.4.2.3. By End User
      • 7.2.4.5. Spain Cardiopulmonary Stress Testing System Market Outlook
        • 7.2.4.5.1. Market Size & Forecast
        • 7.2.4.5.1.1. By Value
        • 7.2.4.5.2. Market Share & Forecast
        • 7.2.4.5.2.1. By Product
        • 7.2.4.5.2.2. By Application
        • 7.2.4.5.2.3. By End User

8. Asia Pacific Cardiopulmonary Stress Testing System Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. China Cardiopulmonary Stress Testing System Market Outlook
        • 8.2.4.1.1. Market Size & Forecast
        • 8.2.4.1.1.1. By Value
        • 8.2.4.1.2. Market Share & Forecast
        • 8.2.4.1.2.1. By Product
        • 8.2.4.1.2.2. By Application
        • 8.2.4.1.2.3. By End User
      • 8.2.4.2. India Cardiopulmonary Stress Testing System Market Outlook
        • 8.2.4.2.1. Market Size & Forecast
        • 8.2.4.2.1.1. By Value
        • 8.2.4.2.2. Market Share & Forecast
        • 8.2.4.2.2.1. By Product
        • 8.2.4.2.2.2. By Application
        • 8.2.4.2.2.3. By End User
      • 8.2.4.3. South Korea Cardiopulmonary Stress Testing System Market Outlook
        • 8.2.4.3.1. Market Size & Forecast
        • 8.2.4.3.1.1. By Value
        • 8.2.4.3.2. Market Share & Forecast
        • 8.2.4.3.2.1. By Product
        • 8.2.4.3.2.2. By Application
        • 8.2.4.3.2.3. By End User
      • 8.2.4.4. Japan Cardiopulmonary Stress Testing System Market Outlook
        • 8.2.4.4.1. Market Size & Forecast
        • 8.2.4.4.1.1. By Value
        • 8.2.4.4.2. Market Share & Forecast
        • 8.2.4.4.2.1. By Product
        • 8.2.4.4.2.2. By Application
        • 8.2.4.4.2.3. By End User
      • 8.2.4.5. Australia Cardiopulmonary Stress Testing System Market Outlook
        • 8.2.4.5.1. Market Size & Forecast
        • 8.2.4.5.1.1. By Value
        • 8.2.4.5.2. Market Share & Forecast
        • 8.2.4.5.2.1. By Product
        • 8.2.4.5.2.2. By Application
        • 8.2.4.5.2.3. By End User

9. South America Cardiopulmonary Stress Testing System Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Brazil Cardiopulmonary Stress Testing System Market Outlook
        • 9.2.4.1.1. Market Size & Forecast
        • 9.2.4.1.1.1. By Value
        • 9.2.4.1.2. Market Share & Forecast
        • 9.2.4.1.2.1. By Product
        • 9.2.4.1.2.2. By Application
        • 9.2.4.1.2.3. By End User
      • 9.2.4.2. Argentina Cardiopulmonary Stress Testing System Market Outlook
        • 9.2.4.2.1. Market Size & Forecast
        • 9.2.4.2.1.1. By Value
        • 9.2.4.2.2. Market Share & Forecast
        • 9.2.4.2.2.1. By Product
        • 9.2.4.2.2.2. By Application
        • 9.2.4.2.2.3. By End User
      • 9.2.4.3. Colombia Cardiopulmonary Stress Testing System Market Outlook
        • 9.2.4.3.1. Market Size & Forecast
        • 9.2.4.3.1.1. By Value
        • 9.2.4.3.2. Market Share & Forecast
        • 9.2.4.3.2.1. By Product
        • 9.2.4.3.2.2. By Application
        • 9.2.4.3.2.3. By End User

10. Middle East & Africa Cardiopulmonary Stress Testing System Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
      • 10.2.4.1. South Africa Cardiopulmonary Stress Testing System Market Outlook
        • 10.2.4.1.1. Market Size & Forecast
        • 10.2.4.1.1.1. By Value
        • 10.2.4.1.2. Market Share & Forecast
        • 10.2.4.1.2.1. By Product
        • 10.2.4.1.2.2. By Application
        • 10.2.4.1.2.3. By End User
      • 10.2.4.2. Saudi Arabia Cardiopulmonary Stress Testing System Market Outlook
        • 10.2.4.2.1. Market Size & Forecast
        • 10.2.4.2.1.1. By Value
        • 10.2.4.2.2. Market Share & Forecast
        • 10.2.4.2.2.1. By Product
        • 10.2.4.2.2.2. By Application
        • 10.2.4.2.2.3. By End User
      • 10.2.4.3. UAE Cardiopulmonary Stress Testing System Market Outlook
        • 10.2.4.3.1. Market Size & Forecast
        • 10.2.4.3.1.1. By Value
        • 10.2.4.3.2. Market Share & Forecast
        • 10.2.4.3.2.1. By Product
        • 10.2.4.3.2.2. By Application
        • 10.2.4.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Technology Launches

13. Competitive Landscape

  • 13.1. Koninklijke Philips NV.
    • 13.1.1. Business Overview
    • 13.1.2. Application Offerings
    • 13.1.3. Recent Developments
    • 13.1.4. Key Personnel
    • 13.1.5. SWOT Analysis
  • 13.2. Hillrom Services Inc.
  • 13.3. General Electric Company
  • 13.4. MGC Diagnostics Corporation.
  • 13.5. OSI Systems Inc.
  • 13.6. Schiller AG
  • 13.7. NIHON KOHDEN CORPORATION
  • 13.8. Vyaire Medical, Inc.
  • 13.9. Halma plc (SunTech Medical, Inc.)
  • 13.10. Cosmed srl

14. Strategic Recommendations

15. About us & Disclaimer